These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 1634608)

  • 21. Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis.
    Ksontini R; Colagiovanni DB; Josephs MD; Edwards CK; Tannahill CL; Solorzano CC; Norman J; Denham W; Clare-Salzler M; MacKay SL; Moldawer LL
    J Immunol; 1998 Apr; 160(8):4082-9. PubMed ID: 9558119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sphingosine-1-phosphate receptor agonists suppress concanavalin A-induced hepatic injury in mice.
    Kaneko T; Murakami T; Kawana H; Takahashi M; Yasue T; Kobayashi E
    Biochem Biophys Res Commun; 2006 Jun; 345(1):85-92. PubMed ID: 16674913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1-Methylnicotinamide protects against liver injury induced by concanavalin A via a prostacyclin-dependent mechanism: A possible involvement of IL-4 and TNF-α.
    Jakubowski A; Sternak M; Jablonski K; Ciszek-Lenda M; Marcinkiewicz J; Chlopicki S
    Int Immunopharmacol; 2016 Feb; 31():98-104. PubMed ID: 26709075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment with dihydroquercetin, a dietary flavonoid, protected against concanavalin A-induced immunological hepatic injury in mice and TNF-α/ActD-induced apoptosis in HepG2 cells.
    Chen J; Sun X; Xia T; Mao Q; Zhong L
    Food Funct; 2018 Apr; 9(4):2341-2352. PubMed ID: 29589006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretreatment with TCDD exacerbates liver injury from Concanavalin A: critical role for NK cells.
    Fullerton AM; Roth RA; Ganey PE
    Toxicol Sci; 2013 Nov; 136(1):72-85. PubMed ID: 23970800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis.
    Mizuhara H; Uno M; Seki N; Yamashita M; Yamaoka M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
    Hepatology; 1996 Jun; 23(6):1608-15. PubMed ID: 8675184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concanavalin-A-induced liver injury is severely impaired in mice deficient in P-selectin.
    Massaguer A; Perez-Del-Pulgar S; Engel P; Serratosa J; Bosch J; Pizcueta P
    J Leukoc Biol; 2002 Aug; 72(2):262-70. PubMed ID: 12149416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The differential effects of low dose and high dose concanavalin A on cytokine profile and their importance in liver injury.
    Xu X; Wei H; Dong Z; Chen Y; Tian Z
    Inflamm Res; 2006 Apr; 55(4):144-52. PubMed ID: 16807695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of intrasinusoidal hemostasis in the development of concanavalin A-induced hepatic injury in mice.
    Miyazawa Y; Tsutsui H; Mizuhara H; Fujiwara H; Kaneda K
    Hepatology; 1998 Feb; 27(2):497-506. PubMed ID: 9462649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice.
    Louis H; Le Moine O; Peny MO; Quertinmont E; Fokan D; Goldman M; Devière J
    Hepatology; 1997 Jun; 25(6):1382-9. PubMed ID: 9185757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice.
    Kato J; Okamoto T; Motoyama H; Uchiyama R; Kirchhofer D; Van Rooijen N; Enomoto H; Nishiguchi S; Kawada N; Fujimoto J; Tsutsui H
    Hepatology; 2013 Jan; 57(1):362-72. PubMed ID: 22936459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allicin, the active component of garlic, prevents immune-mediated, concanavalin A-induced hepatic injury in mice.
    Bruck R; Aeed H; Brazovsky E; Noor T; Hershkoviz R
    Liver Int; 2005 Jun; 25(3):613-21. PubMed ID: 15910499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism.
    Li B; Sun R; Wei H; Gao B; Tian Z
    Hepatology; 2006 Jun; 43(6):1211-9. PubMed ID: 16729307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-activation of T lymphocytes by low dose of concanavalin A aggravates toll-like receptor-3 ligand-induced NK cell-mediated liver injury.
    Wang J; Sun R; Wei H; Dong Z; Tian Z
    Int Immunopharmacol; 2006 May; 6(5):800-7. PubMed ID: 16546711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of immunosuppressants on concanavalin A-induced interleukin-2 mRNA expression in mouse liver.
    Okamoto T; Kobayashi T
    Jpn J Pharmacol; 1998 Jul; 77(3):261-3. PubMed ID: 9717775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice.
    Volarevic V; Milovanovic M; Ljujic B; Pejnovic N; Arsenijevic N; Nilsson U; Leffler H; Lukic ML
    Hepatology; 2012 Jun; 55(6):1954-64. PubMed ID: 22213244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paeoniflorin protects against concanavalin A-induced hepatitis in mice.
    Chen M; Cao L; Luo Y; Feng X; Sun L; Wen M; Peng S
    Int Immunopharmacol; 2015 Jan; 24(1):42-9. PubMed ID: 25479726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ginsenoside Rg1 attenuates concanavalin A-induced hepatitis in mice through inhibition of cytokine secretion and lymphocyte infiltration.
    Cao L; Zou Y; Zhu J; Fan X; Li J
    Mol Cell Biochem; 2013 Aug; 380(1-2):203-10. PubMed ID: 23666740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated concanavalin A challenge in mice induces an interleukin 10-producing phenotype and liver fibrosis.
    Louis H; Le Moine A; Quertinmont E; Peny MO; Geerts A; Goldman M; Le Moine O; Devière J
    Hepatology; 2000 Feb; 31(2):381-90. PubMed ID: 10655261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment with propylene glycol alginate sodium sulfate ameliorated concanavalin A-induced liver injury by regulating the PI3K/Akt pathway in mice.
    Xu S; Wu L; Zhang Q; Feng J; Li S; Li J; Liu T; Mo W; Wang W; Lu X; Yu Q; Chen K; Xia Y; Lu J; Xu L; Zhou Y; Fan X; Guo C
    Life Sci; 2017 Sep; 185():103-113. PubMed ID: 28774703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.